Disc Medicine Inc (IRON)

Currency in USD
79.82
+0.28(+0.35%)
Closed·
79.84+0.02(+0.03%)
·
IRON is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
79.2281.24
52 wk Range
30.8299.50
Key Statistics
Prev. Close
79.54
Open
79.26
Day's Range
79.22-81.24
52 wk Range
30.82-99.5
Volume
329.96K
Average Volume (3m)
587.93K
1-Year Change
25.09%
Book Value / Share
16.49
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IRON Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
121.67
Upside
+52.43%
Members' Sentiments
Bearish
Bullish
ProTips
8 analysts have revised their earnings downwards for the upcoming period

Disc Medicine Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Disc Medicine Company Profile

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. It also develops preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.

Disc Medicine Inc SWOT Analysis


Pipeline Promise
Disc Medicine's bitopertin and DISC-0974 show potential in rare blood disorders, with NDA filing for bitopertin expected in late 2025
Market Opportunity
Expanded patient estimates for EPP/XLP and substantial anemia treatment market present significant revenue potential for Disc Medicine
Catalysts Ahead
Key milestones include NDA filing, Phase 2 data readouts, and new trial initiations, potentially driving stock performance and valuation
Analyst Optimism
Price targets range from $75 to $132, reflecting confidence in Disc Medicine's pipeline and market potential despite current unprofitability
Read full SWOT analysis

Compare IRON to Peers and Sector

Metrics to compare
IRON
Peers
Sector
Relationship
P/E Ratio
−16.6x−9.0x−0.6x
PEG Ratio
0.44−0.080.00
Price/Book
5.3x4.8x2.6x
Price / LTM Sales
-43.0x3.2x
Upside (Analyst Target)
45.8%61.9%41.8%
Fair Value Upside
Unlock−9.4%5.1%Unlock

Analyst Ratings

13 Buy
0 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 121.67
(+52.43% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Stifel
Buy125.00+56.60%-Maintain19/12/2025
Jefferies
Buy154.00+92.93%-Maintain19/12/2025
BMO Capital
Buy120.00+50.34%-Maintain19/12/2025
Wells Fargo
Buy109.00+36.56%91.00Maintain16/12/2025
H.C. Wainwright
Buy118.00+47.83%-Maintain09/12/2025

Earnings

Latest Release
Nov 06, 2025
EPS / Forecast
-1.77 / -1.48
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

20.41
DYN
-1.78%
11.03
SPRY
-2.90%
35.41
IDYA
-0.25%
77.30
APGE
-0.90%
47.81
PCVX
-0.54%

FAQ

What Is the Disc Medicine (IRON) Share Price Today?

The live Disc Medicine share price today is 79.82

What Stock Exchange Does Disc Medicine (IRON) Trade On?

Disc Medicine is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Disc Medicine?

The stock symbol (also called a 'ticker') for Disc Medicine is "IRON."

What Is the Current Disc Medicine Market Cap?

As of today, Disc Medicine market capitalisation is 3.01B.

What Is Disc Medicine's (IRON) Earnings Per Share (TTM)?

The Disc Medicine EPS is currently -5.42 (Trailing Twelve Months).

When Is the Next Disc Medicine Earnings Date?

Disc Medicine's next earnings report will be released on 27 Mar 2026.

Is IRON a Buy or Sell From a Technical Analyst Perspective?

Based on today's Disc Medicine moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Disc Medicine Stock Split?

Disc Medicine has split 1 times. (See the IRON stock split history page for full effective split date and price information.)

How Many Employees Does Disc Medicine Have?

Disc Medicine has 142 employees.

What is the current trading status of Disc Medicine (IRON)?

As of 24 Dec 2025, Disc Medicine (IRON) is trading at a price of 79.82, with a previous close of 79.54. The stock has fluctuated within a day range of 79.22 to 81.24, while its 52-week range spans from 30.82 to 99.50.

What Is Disc Medicine (IRON) Price Target According to Analysts?

The average 12-month price target for Disc Medicine is USD121.66667, with a high estimate of USD154 and a low estimate of USD109. 13 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +52.43% Upside potential.

What Is the IRON Premarket Price?

IRON's last pre-market stock price is 80.00. The pre-market share volume is 400.00, and the stock has decreased by 0.46, or 0.58%.

What Is the IRON After Hours Price?

IRON's last after hours stock price is 79.84, the stock has decreased by 0.02, or 0.03%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.